Business Updates:
• Oncology business is expected to grow well.
• CRM manufacturing of API and ARV and Non ARV segment is seen good growth.
• Adding manufacturing facility for ARV and Non ARV.
• Revenue share mentioned in image.
• Acquire land at Vizag at existing facility for increasing capacity.
• Planning to buy land for Laurus Bio.
• Planning for separate Synthesis company as company is planning to expand well in these segment.
• Most of US sales is contract manufacturing
"Big Pond (Industry Scope) with few Big Fishes (less players) seems good. But Uncertainty and Fear of Competitor can also tamper down the growing size of Fish (stable growth)"
Here are the key insights 😀
Business Updates:
• Total Traffic grew by 44%.
• 80 Millions every month which was 52 Million last year same month.
• For beginning of this quarter company came to pre covid level and in quarter end there is 4000 net addition and supplier base of 1,52,000.
• Company is continue focusing on acquisition as well.
• 1070 crores QIP was successful in Q4 which will be utilized for expansion.
Business Updates:
• Revenue drop YoY, however volumes is same.
• Autonomous driving trend is long term trend which requires software for multiple use.
• Shared Mobility is also showing good trend. For this vehicle replacement with software inbuilt can be seen.
• Company has made strategies to intake efficient employees
• Company focus is to attract few clients but to have very long term plan with those customers.